SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-129986
Filing Date
2024-05-03
Accepted
2024-05-03 08:03:57
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-05-03

Document Format Files

Seq Description Document Type Size
1 ARS d507576dars.pdf ARS 8954575
  Complete submission text file 0001193125-24-129986.txt   12335708
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39634 | Film No.: 24910842
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)